Cryptopine (Isoquinoline Alkaloid · Sedative · Opium Minor Reference)
| Compound | Cryptopine (α-Cryptopine; 14-Methylnarcotine analogue) |
| Class | Alkaloid — Phthalideisoquinoline (Isoquinoline subclass) |
| CAS | 482-74-6 |
| Molecular formula | C₂₁H₂₃NO₅ |
| Primary sources | Papaver somniferum, Chelidonium majus, Corydalis spp. |
| Plant part | Capsule latex, roots, aerial parts |
| Claim strength | Emerging |
| Key applications | Mild sedative reference; anticonvulsant; antispasmodic; informational-only |
| Buy from Herbuno | Informational reference — see HerbIQ Compound Index → |
Name origin: Cryptopine was named "crypto-" (hidden) pine — originally believed to be a hidden or masked form of opine alkaloids, reflecting early confusion about its structural relationship to other opium constituents. It belongs to the phthalideisoquinoline class (same as noscapine/narcotine), sharing the bicyclic phthalide ring system fused to the tetrahydroisoquinoline scaffold. Traditional use: Cryptopine does not have independent traditional use but occurs in plants with established medicinal histories. Chelidonium majus (celandine) — in which cryptopine is a significant minor constituent — is used in European herbal medicine for biliary spasm, liver conditions, and wart treatment. Corydalis yanhusuo, another cryptopine source, is a major TCM analgesic and sedative herb. The presence of cryptopine in these plants contributes to their antispasmodic pharmacology. Research trajectory: Cryptopine has been characterised as a mild sedative and anticonvulsant in rodent models, with antispasmodic activity on smooth muscle. Its pharmacological profile overlaps with noscapine (both phthalideisoquinolines) but at lower potency. Safety context: Cryptopine has low acute toxicity in animal models. As a Papaver somniferum constituent, it is associated with opiate regulatory frameworks, though it has no significant opioid activity.
Pharmacological Profile of Cryptopine
Sedative and anticonvulsant activity: Cryptopine prolongs pentobarbital-induced sleep in rodents and reduces pentylenetetrazol-induced seizure severity in animal models, consistent with mild CNS depressant activity. The mechanism may involve GABAergic modulation or sigma receptor interaction, though specific receptor pharmacology is incompletely characterised. Claim strength: Emerging.
Antispasmodic activity: On isolated smooth muscle preparations (ileum, uterus, trachea), cryptopine reduces contractility in a dose-dependent manner. This activity parallels papaverine's smooth muscle relaxant mechanism (PDE inhibition) but at lower potency. In the context of Chelidonium or Corydalis extracts, cryptopine contributes to their antispasmodic profile. Claim strength: Emerging.
Antimicrobial activity: Cryptopine demonstrates moderate antibacterial activity against Gram-positive organisms and Mycobacterium tuberculosis in disc diffusion assays. This activity is consistent with the phthalideisoquinoline alkaloid class broadly. Claim strength: Emerging.
Antiproliferative: Micromolar concentrations of cryptopine inhibit proliferation in several cancer cell lines with selectivity for certain cell types, suggesting interaction with cell cycle regulatory proteins. Research is early-stage. Claim strength: Emerging.
This compound is documented for research and formulator education purposes. For commercially available botanical ingredients, explore the HerbIQ Compound Index →
Regulatory and Formulator Context
Cryptopine is a constituent of Papaver somniferum and is thus subject to opiate regulatory frameworks by association in most jurisdictions, despite lacking significant opioid receptor activity. It is also found in Chelidonium and Corydalis — plants with established herbal medicine use not subject to narcotic plant controls.
Formulators working with Chelidonium majus extract (for biliary and antispasmodic applications) or Corydalis yanhusuo extract (for analgesic/sleep applications) will co-deliver cryptopine as part of the total alkaloid matrix. At extract doses standard for these herbs, cryptopine's contribution to pharmacological effects is minor relative to chelidonine (Chelidonium) or tetrahydropalmatine/corydaline (Corydalis).
Isolated cryptopine is not available as a commercial supplement ingredient. Its pharmacological profile does not present a clear commercial opportunity distinct from the parent herb extracts in which it occurs naturally.
No significant adverse effects are documented for cryptopine at typical extract exposure levels. Chelidonium major extract has hepatotoxicity concerns at high doses due to its total alkaloid content — a caution applicable to the whole-plant extract rather than cryptopine specifically.
Frequently Asked Questions — Cryptopine
What is the phthalideisoquinoline alkaloid class?
Phthalideisoquinolines are a structural subclass of isoquinoline alkaloids in which the benzylisoquinoline skeleton is cyclised to form a bicyclic phthalide (isobenzofuranone) ring. Noscapine (narcotine) is the most pharmacologically important phthalideisoquinoline — the non-addictive antitussive from opium. Cryptopine shares this structural class, as do hydrastine and bicuculline (the GABA-A antagonist research tool compound).
How does cryptopine compare to noscapine pharmacologically?
Both are phthalideisoquinolines from Papaver somniferum, but noscapine has been significantly more studied and developed. Noscapine has high-quality antitussive evidence and emerging oncology research (tubulin binding, apoptosis induction). Cryptopine's pharmacological profile — sedative, antispasmodic, antimicrobial — is less developed and lacks clinical translation. Noscapine is the commercially meaningful phthalideisoquinoline in this plant.
Is cryptopine present in Corydalis (Yan Hu Suo) extracts?
Yes — Corydalis yanhusuo contains a complex alkaloid mixture including tetrahydropalmatine (the primary analgesic/sedative active), corydaline, protopine, and cryptopine among others. Commercial Corydalis extracts are typically standardised to tetrahydropalmatine content; cryptopine is a co-occurring minor alkaloid not routinely quantified in supplement-grade material.
Is cryptopine different from cryptopine in early alkaloid literature?
Early 19th-century alkaloid chemistry produced confusing nomenclature for minor opium alkaloids. What was called "cryptopine" was occasionally misidentified or conflated with related phthalideisoquinolines (particularly hydrastine). Modern structural characterisation by NMR and MS has unambiguously established cryptopine's (CAS 482-74-6) identity, resolving historical nomenclature issues.
Related compounds: Neopine, Chelidonine, Protopine, Noscapine
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery